The Metabolism and Pharmacokinetics of Acrylamide: Implications for Mechanisms of Toxicity and Human Risk Estimation

References

• Abou-Donia M. B., Ibrahim S. M., Corcoran J. J., Lack L., Friedman M. A., Lapadula D. M. Neurotoxicity of glycidamide, an acryiamide metabolite, following intraperitoneal injections in rat. J. Toxicol. Environ. Health 1993; 39: 447–464
   PubMed Web of Science ®Google Scholar
• Adler I.-D. Clastogenic effects of acryiamide in different germ-cell stages of male mice. Banbury Rep. 34: Biology of Mammalian Germ Cell Mutagensis. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1990
   Google Scholar
• Agrawal A. K., Seth P. K., Squibb R. E., Tilson H. A., Uphouse L. L., Bondy S. C. Neurotransmitter receptors in brain regions of acrylamide-treated rats. I. Effects of a single exposure to acryiamide. Pharmacol. Biochem. Behav 1981; 14: 527–531
   PubMed Web of Science ®Google Scholar
• American Cyanamid Co. Final report: A life-time oncogenicity study in rats with acryiamide. Wayne, NJ 1989, June 27, Study No. 85033
   Google Scholar
• Bachmann M., Myers J. E., Bezuidenhout S. S. Acryiamide monomer and peripheral neuropathy in chemical workers. Am. J. Ind. Med. 1992; 21: 217–222
   PubMed Web of Science ®Google Scholar
• Backer L. C., Dearfield K. L., Erexson G. L., Campbell J. A., West-brook-Collins B., Allen J. W. The effect of acryiamide on mouse germ-line and somatic cell chromosomes. Environ. Mol. Mutagen 1989; 13: 218–226
   PubMedGoogle Scholar
• Bailey E., Farmer P. B., Bird I., Lamb J. H., Peal J. A. Monitoring exposure to acryiamide by the determination of S-(2-carboxyethyl)cysteine in hydrolyzed hemoglobin by gas chromatography-mass spectrometry. Anal. Biochem 1986; 157: 241–248
   PubMed Web of Science ®Google Scholar
• Banerjee S., Segal A. In vitro transformation of C3H/10T1/ 2 and NIH/3T3 cells by acrylonitrile and acryiamide. Cancer Lett 1986; 32: 293–304
   PubMed Web of Science ®Google Scholar
• Barfknecht T. R., Mecca D. J., Naismith R. W. The gen-otoxic activity of acrylamide. Environ. Mol. Mutagen. 1988; 11(Suppl. 11), Abstract 18
   Google Scholar
• Beiswager C. M., Mandella R. D., Graessle T. R., Reuhl K. R., Lowndes H. E. Synergistic neurotoxic effects of styrene oxide and acrylamide: Glutathione-independent necrosis of cerebellar granule cells. Toxicol. Appl. Pharmacol 1993; 118: 233–244
   PubMed Web of Science ®Google Scholar
• Beranek D. T., Weis C. C., Swenson D. H. A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis 1980; 1: 595–606
   PubMed Web of Science ®Google Scholar
• Bergmark E. Hemoglobin dosimetry and comparative toxicity of acrylamide and its metabolite glycidamide. Thesis, University of Stockholm. 1992
   Google Scholar
• Bergmark E., Calleman C. J., Costa L. G. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol. Appl. Pharmacol 1991; 111: 352–363
   PubMed Web of Science ®Google Scholar
• Bergmark E., Calleman C. J., He F., Costa L. G. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol 1993; 120: 45–54
   PubMed Web of Science ®Google Scholar
• Brat D. J., Brimijoin S. Acrylamide and glycidamide impair neurite outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bidirectional transport of organellas observed by video microscopy. J. Neurochem 1993; 60: 2145–2152
   PubMed Web of Science ®Google Scholar
• Brismar T., Hildebrand C., Tegner R. Nodes of Ranvier in acrylamide neuropathy: Voltage clamp and electron microscopic analysis of rat sciatic nerve fibres at proximal levels. Brain Res 1987; 423: 135–143
   PubMed Web of Science ®Google Scholar
• Broxup B., Robinson K., Losos G., Beyroudy P. Correlations between behavioral and pathological changes in the evaluation of neurotoxicity. Toxicol. Appl. Pharmacol 1989; 101: 510–520
   PubMed Web of Science ®Google Scholar
• Bull R. J., Robinson M., Stober J. Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett 1984a; 24: 209–212
   PubMed Web of Science ®Google Scholar
• Bull R. J., Robinson M., Laurie R. D., Stoner G. D., Greisiger E., Meier J. R., Stober J. Carcinogenic effects of acrylamide in SENCAR and A/J mice. Cancer Res 1984b; 44: 107–111
   PubMed Web of Science ®Google Scholar
• Butterworth B. E., Eldridge S. R., Sprankle C. S., Working P. K., Bentley K. S., Hurtt M. E. Tissue-specific genotoxic effects of acrylamide and acrylonitrile. Environ. Mol. Mutagen 1992; 20: 148–155
   PubMed Web of Science ®Google Scholar
• Calleman C. J. In vivo dosimetry by means of alkylated hemoglobin–a tool in die design of tests for genotoxic effects. Banbury Rep. 13: Indicators of Genotoxic Exposures. 1982; 157–168
   Google Scholar
• Calleman C. J. Hemoglobin as a dose monitor and its application to the risk estimation of ethylene oxide. Thesis, University of Stockholm. 1984
   Google Scholar
• Calleman C. J., Bergmark E., Costa L. G. Acrylamide is metabolized to glycidamide in the rat: Evidence from hemoglobin ad-duct formation. Chem. Res. Toxicol 1990; 3: 406–412
   PubMed Web of Science ®Google Scholar
• Calleman C. J., Stern L. G., Bergmark E., Costa L. G. Linear versus nonlinear models for hemoglobin adduct formation by acrylamide and its metabolite glycidamide: Implications for risk estimation. Cancer Epidemiol. Biomarkers Prev 1992; 1: 361–368
   PubMed Web of Science ®Google Scholar
• Calleman C. J., Bergmark E., Stern L. G., Costa L. G. A nonlinear dosimetric model for hemoglobin adduct formation by the neurotoxic agent acrylamide and its genotoxic metabolite glycidamide. Env. Health Perspect 1993; 99: 221–223
   PubMed Web of Science ®Google Scholar
• Calleman C. J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K. M., Fennell T., Costa L. G. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol 1994; 126: 361–367
   PubMed Web of Science ®Google Scholar
• Calleman C. J., He F., Bergmark E., Costa L. G. Determination of hemoglobin adducts as a tool for neurological risk estimation of human exposure to acrylamide. 1996, Manuscript
   Google Scholar
• Carlson G. P., Fossa A. A., Morse M. A., Weaver P. M. Binding and distribution studies in the SENCAR mouse of compounds demonstrating a route-dependent tumorigenic effect. Env. Health Perspect 1986; 68: 53–60
   PubMed Web of Science ®Google Scholar
• Carlson G. P., Weaver P. M. Distribution and binding of 14C-acrylamide to macromolecules in SENCAR and BALB/c mice following oral and topical administration. Toxicol. Appl. Pharmacol 1985; 79: 307–313
   PubMed Web of Science ®Google Scholar
• Carrington C. D., Lapadula D. M., Dulak L., Friedman M., Abou-Donia M. B. In vivo binding of [14C]acrylamide to proteins in the mouse nervous system. Neurochem. Int. 1991; 18: 191–197
   PubMed Web of Science ®Google Scholar
• Collins J. J., Swaen G. M. H., Marsh G. M., Utidjian H. M. D., Caporossi J. C., Lucas L. J. Mortality patterns among workers exposed to acrylamide. J. Occup. Med. 1989; 7: 614–617
   Google Scholar
• Costa L. G., Deng H., Gregotti C., Manzo L., Faustman E. M., Bergmark E., Calleman C. J. Comparative studies on the neuro- and reproductive toxicity of acrylamide and its epoxide metabolite glycidamide in the rat. Neurotoxicology 1992; 13: 219–224
   PubMed Web of Science ®Google Scholar
• Costa L. G., Deng H., Calleman C. J., Bergmark E. Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: Behavioral, neurochemical and morphological studies. Toxicology 1995; 98: 151–161
   PubMed Web of Science ®Google Scholar
• Dearfield K. L., Abernathy C. O., Ottley M. S., Brantner J. H., Hayes P. Acrylamide: Its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat. Res. 1988; 195: 45–77
   PubMed Web of Science ®Google Scholar
• Deng H., He F., Zhang S., Calleman C. J., Costa L. G. Quantitative measurements of vibration thresholds in healthy adults and acrylamide workers. Int. Arch. Occup. Envir. Health 1993; 65: 53–56
   PubMed Web of Science ®Google Scholar
• el-Din A. Y., al-Maskati H. A., Mohamed D. Y., Dairi M. G. Acrylamide as an inducer of metabolic activation system (S9) in rats. Mutat. Res. 1993; 300: 91–97
   PubMed Web of Science ®Google Scholar
• Dixit R., Mukhtar H., Seth P. K., Murti C. R. K. Conjugation of acrylamide with glutathione catalyzed by glutathione-S-transferase of rat liver and brain. Biochem. Pharmacol 1981; 30: 1739–1744
   PubMed Web of Science ®Google Scholar
• Edwards P. M. The distribution and metabolism of acrylamide and its neurotoxic analogues in rats. Biochem. Pharmacol 1975a; 4: 1277–1282
   Google Scholar
• Edwards P. M. Neurotoxicity of acrylamide and its analogues and effects of these analogues and other agents on acrylamide neuropathy. Br. J. Ind. Med. 1975b; 32: 31–38
   PubMedGoogle Scholar
• Ehrenberg L. Genetic toxicity of environmental chemicals. Acta Biol. Iugosl., Ser. F, Genetika 1974; 6: 367–398
   Google Scholar
• EPA: Environmental Protection Agency. Final draft for drinking water criteria document on acrylamide. Office of Drinking Water, USEPA, Washington, DC 1987
   Google Scholar
• EPA: Environmental Protection Agency. Assessment of health risks from exposure to acrylamide. Office of Toxic Substances, USEPA, Washington, DC 1990
   Google Scholar
• EPA: Environmental Protection Agency. Integrated risk information system, acrylamide. 1992, Revised 01/01/92
   Google Scholar
• Farmer P. B., Bailey E., Naylor S., Anderson D., Brooks A., Cushmir J., Lamb J. H., Sepai O., Tang Y.-S. Identification of endogenous electrophiles by means of mass spectrometric determination of protein and DNA adducts. Env. Health Perspect 1993; 99: 19–24
   PubMed Web of Science ®Google Scholar
• Frantz S. W., Dryzga N. L., Freshour N. L., Watanabe P. G. In vivo/in vitro determination of cutaneous penetration of residual monomer from polyacrylamides. Toxicologist 1985; 5, Abstract 39
   Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics. Marcel Dekker, New York 1982; 272–277
   Google Scholar
• Gutierrez-Espeleia G. A., Hughes L. A., Piegorsch W. W., Shelby M. D., Generoso W. M. Acrylamide: Dermal exposure produces genetic damage in male mouse germ cells. Fundam. Appl. Toxicol 1992; 18: 189–192
   PubMedGoogle Scholar
• Hashimoto K., Aldridge W. N. Biochemical studies on acrylamide, a neurotoxic agent. Biochem. Pharmacol 1970; 19: 2591–2604
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Sakamoto J., Tanii H. Neurotoxicity of acrylamide and related compounds and their effects on male gonads in mice. Arch. Toxicol 1981; 47: 179–189
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Tanii H. Mutagenicity of acrylamide and its analogues. Salmonella typhimurium. Mutat. Res. 1985; 158: 129–133
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Hayashi M., Tanii H., Sakamoto J. Toxi-cological aspect of acrylamide neuropathy. J. UOEH 1988; 10(Suppl.)209–218
   Google Scholar
• Hattis D., Shapiro K. Analysis of dose/time/response relationships for chronic toxic effects: The case of acrylamide. Neuro-toxicology 1990; 11: 219–236
   Google Scholar
• He F., Zhang S., Wang H., Li G., Zhang Z., Li F., Dong X., Hu F. Neurological and electroneuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers. Scand. J. Work Environ. Health 1989; 15: 125–129
   PubMed Web of Science ®Google Scholar
• Howland R. D., Ypas I. L., Lowndes H. E. The etiology of acrylamide neuropathy: Possible involvement of neuron specific enolase. Brain Res 1980; 190: 529–535
   PubMed Web of Science ®Google Scholar
• IARC. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, No. 39. Some Chemicals Used in Plastics and Elastomers. IARC, Lyon 1986; 41–66
   Google Scholar
• Ikeda G. J., Miller E., Sapienza P. P., Michel T. C., Inskeep P. B. Comparative tissue distribution and excretion of [l-14C]acrylamide in beagle dogs and miniature pigs. Food Chem. Toxicol 1987; 25: 871–875
   PubMed Web of Science ®Google Scholar
• Jakubowski M., Linhart I., Pielas G., Kopecky J. 2-Cyano-ethylmercapturic acid (CEMA) in the urine as a possible indicator of exposure to acrylonitrile. Br. J. Ind. Med. 1987; 44: 834–840
   PubMedGoogle Scholar
• Johnson K. S., Gorzinski S., Bodner R., Campbell R., Wolf C., Friedman M., Mast R. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol 1986; 85: 154–168
   PubMed Web of Science ®Google Scholar
• Kaplan M. L., Murphy S. D., Gilles F. H. Modification of acrylamide neuropathy in rats by selected factors. Toxicol. Appl. Pharmacol 1973; 85: 154–168
   Google Scholar
• Kedderis G. L., Batra R. Species differences in the hydrolysis of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. Carcinogenesis 1993; 14: 685–689
   PubMed Web of Science ®Google Scholar
• King D. J., Noss R. R. Toxicity of polyacrylamide and acrylamide monomer. Rev. Environ. Health 1989; 8: 3–15
   PubMedGoogle Scholar
• Knaap A. G. A. C., Kramers P. G. N., Voogd C. E., Bergkamp W. G. M., Groot M. G., Langebroek P. G., Mout H. C. A., van der Stel J. J., Verharen H. W. Mutagenic activity of acrylamide in eukaryotic systems but not in bacteria. Mutagenesis 1988; 3: 263–268
   PubMed Web of Science ®Google Scholar
• Kotlovsky Yu., Grishanova A., Ivanov V. V. Effect of memylmethacrylate and acrylamide on the system of microsomal oxidation in rat liver tissue. Vopr. Med. Khim 1984; 30: AA–A1
   Google Scholar
• Lijinsky W., Andrews A. W. Mutagenicity of vinyl compounds. Salmonella typhimurium. Teratogen. Carcinogen. Mutagen 1980; 1: 259–267
   PubMedGoogle Scholar
• Marlowe C., Clark M. J., Mast R. W., Friedman M. A., Waddell W. J. The distribution of [14C]acrylamide in male and pregnant Swiss-Webster mice studied by whole-body autoradiography. Toxicol. Appl. Pharmacol 1986; 86: 457–465
   PubMed Web of Science ®Google Scholar
• Matsuoka M., Igisu H., Lin J., Inoue N. Effects of acrylamide and NN'-methylene-bis-acrylamide on creatine kinase activity. Brain Res 1990; 507: 351–353
   PubMed Web of Science ®Google Scholar
• Miller M. J., Carter D. E., Sipes I. G. Pharmacokinetics of acrylamide in Fisher-344 rats. Toxicol. Appl. Pharmacol 1982; 63: 36–44
   PubMed Web of Science ®Google Scholar
• Miller M. J., McQueen C. The effect of acrylamide on hepatocellular DNA repair. Environ. Mutagen 1986; 8: 99–108
   PubMedGoogle Scholar
• Miller M. S., Spencer P. S. The mechanism of acrylamide axonopathy. Ann. Rev. Pharmacol. Toxicol 1985; 25: 643–666
   PubMed Web of Science ®Google Scholar
• Moore M. M., Amtower A., Doerr C., Brock K. H., Dearfield K. L. Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells. Environ. Mutagen 1987; 9: 261–267
   PubMedGoogle Scholar
• Myers J. E., Macun I. Acrylamide neuropathy in a South African factory: An epidemiological investigation. Am. J. Ind. Med. 1991; 19: 487–493
   PubMed Web of Science ®Google Scholar
• Neuhäuser-Klaus A., Schmahl W. Mutagenic and teratogenic effects of acrylamide in the mammalian spot test. Mutat. Res. 1989; 226: 157–162
   PubMed Web of Science ®Google Scholar
• NIOSH: National Institute of Occupational Safety and Health. NIOH and NIOSH Basis for an Occupational Health Standard. Acrylamide: A Review of the Literature. Cincinnati, OH 1991, DHHS (NIOSH) Publication No. 91–115
   Google Scholar
• Okajiwa Y., Maloney F. P. Overwork weakness in rats with acrylamide neuropathy. Am. J. Phys. Med. Rehabil 1989; 68: 66–69
   PubMed Web of Science ®Google Scholar
• Ortiz E., Patel J. M., Leibman K. C. Specific inactivation of aniline hydroxylase by a reactive intermediate formed during acrylamide biotransformation by rat liver microsomes. Adv. Exp. Med. Biol 1981; 136: 1221–1227
   PubMed Web of Science ®Google Scholar
• O'Shaugnessy D. J., Losos G. J. Comparison of central and peripheral nervous system lesions caused by high-dose short-term and low-dose subchronic acrylamide treatment in rats. Toxicol. Pathol 1986; 14: 389–394
   PubMedGoogle Scholar
• Osterman-Golkar S., Ehrenberg L., Segerbäck D., Hällström I. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat. Res. 1976; 34: 1–10
   PubMed Web of Science ®Google Scholar
• Osterman-Golkar S., Farmer P. B., Segerbäck D., Bailey E., Calleman C. J., Svenson K., Ehrenberg L. Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin. Teratogen. Carcinogen. Mutagen 1983; 3: 395–405
   PubMedGoogle Scholar
• Osterman-Golkar S., MacNeela J. P., Turner M. J., Walker V., Swenberg J. A., Sumner S. J., Youtsey N., Fennel T. R. Monitoring of exposure to acrylonitrile using adducts with N-terminal valine in hemoglobin. Carcinogenesis 1994; 15: 2701–2707
   PubMed Web of Science ®Google Scholar
• Pastoor T., Heydens W., Richardson R. J. Time- and dose-related excretion of acrylamide metabolites in the urine of Fisher-344 rats. Toxicol. Lett 1980, No. 1: 215, S. I
   Google Scholar
• Pastoor T., Richardson R. J. Blood dynamics of acrylamide in rats. Toxicologist 1981; 1: 53
   Google Scholar
• Ramsey J. C., Young J. D., Gorzinski S. J. Acrylamide: Toxicodynamics in rats. Dow Chemical Company, Midland, MI 1984, Unpublished report
   Google Scholar
• Raymer J. H., Sparacino C. M., Velez G. R., Padilla S., MacPhail R. C., Crofton K. M. Analysis of acrylamide in rat serum and sciatic nerve by gas chromatography/electron capture detection of the derivative, 2-bromopropenamide. J. Chromatogr. Biomed. Appl 1993; 619: 223–234
   Google Scholar
• Russell L. B., Hunsicker P. R., Cacheiro N. L. A., Generoso W. M. Induction of specific-locus mutations in male germ cells of the mouse by acrylamide monomer. Mutat. Res. 1991; 262: 101–107
   PubMed Web of Science ®Google Scholar
• Sabri M. I. In vitro and in vivo inhibition of glycolytic enzymes by acrylamide. Neurochem. Pathol 1983; 1: 179–191
   Google Scholar
• Sabri M. I. Acrylamide impairs fast and slow axonal transport in rat optic system. Neurochem. Res. 1990; 15: 603–608
   PubMed Web of Science ®Google Scholar
• Sakamoto J., Hashimoto K. Reproductive toxicity of acrylamide and related compounds in mice–effects on fertility and sperm morphology. Arch Toxicol 1986; 59: 201–205
   PubMed Web of Science ®Google Scholar
• Schoental R., Cavanagh J. B. Mechanisms involved in the “dying-back” process–an hypothesis implicating coenzymes. Neuropathol. Appl. Neurobiol 1977; 3: 145–157
   Web of Science ®Google Scholar
• Sega G. A., Valdivia Alcota R. P., Tancongco C. P., Brimer P. Acrylamide binding to the DNA and protamine of spermiogenic stages in the mouse and its relationship to genetic damage. Mutat. Res. 1989; 216: 221–230
   PubMed Web of Science ®Google Scholar
• Sega G. A., Generoso E. E., Brimer P. A. Acrylamide exposure induces a delayed unscheduled DNA synthesis in germ cells of male mice that is correlated with the temporal pattern of adduct formation in testis DNA. Environ. Mol. Mutagen 1990; 16: 137–142
   PubMed Web of Science ®Google Scholar
• Segerbäck D. Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide. Chem.-Biol. Interact 1983; 45: 139–151
   PubMed Web of Science ®Google Scholar
• Segerbäck D., Calleman C. J., Schroeder J. L., Costa L. G., Faustman E. M. Formation of N-7-(2-carbamoyl-2-hydroxy-ethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 1995; 16: 1161–1165
   PubMed Web of Science ®Google Scholar
• Shelby M. D., Cain K. T., Hughes L. A., Braden P. W., Generoso W. M. Dominant lethal effects of acrylamide in male mice. Mutat. Res. 1986; 173: 273–278
   PubMed Web of Science ®Google Scholar
• Shelby M. D., Cain K. T., Cornett C. V., Generoso W. M. Acrylamide: Induction of heritable translocations in male mice. Environ. Mutagen 1987; 9: 363–368
   PubMedGoogle Scholar
• Shiraishi T. Chromosome aberrations induced by monomeric acrylamide in bone marrow and germ cells of mice. Mutat. Res. 1978; 57: 313–324
   PubMed Web of Science ®Google Scholar
• Smith E. A., Oehme F. W. Acrylamide and polyacrylamide: A review of production, use, environmental fate and neurotoxicity. Rev. Env. Health 1991; 9: 215–228
   PubMedGoogle Scholar
• Smith M. K., Zenick H., Preston R. J., George E. L., Long R. E. Dominant lethal effects of subchronic acrylamide administration in the male Long-Evans rat. Mutat. Res. 1986; 173: 273–277
   PubMed Web of Science ®Google Scholar
• Snellings W. M., Weil C. S., Maronpot R. R. A two-year inhalation study of the carcinogenic potential of ethylene oxide in Fischer 344 rats. Toxicol. Appl. Pharmacol 1984; 75: 105–117
   PubMed Web of Science ®Google Scholar
• Sobel W., Bond G. G., Parsons T. W., Brenner F. E. Acrylamide cohort mortality study. Br. J. Ind. Med. 1986; 43: 785–788
   PubMedGoogle Scholar
• Solomon J. J., Fedyk J., Mukai F., Segal A. Direct alkylation of 2′-deoxynucleosides and DNA following in vitro reaction with acrylamide. Cancer Res 1985; 45: 3465–3470
   PubMed Web of Science ®Google Scholar
• Srivastava S. P., Seth P. K., Das M., Mukhtar H. Effects of mixed-function oxidase modifiers on neurotoxicity of acrylamide in rats. Biochem. Pharmacol 1985; 34: 1099–1102
   PubMed Web of Science ®Google Scholar
• Sumner S. C. J., MacNeela J. P., Fennell T. R. Characterization and quantitation of urinary metabolites of [1,2,3−13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol 1992; 5: 81–89
   PubMed Web of Science ®Google Scholar
• Svensson K., Osterman-Golkar S. Kinetics of metabolism of propene and covalent binding to macromolecules in the mouse. Toxicol. Appl. Pharmacol 1984; 73: 363–372
   PubMed Web of Science ®Google Scholar
• Tilson H. A. The neurotoxicity of acrylamide: An overview. Neurobehav. Toxicol. Teratol 1981; 3: 445–461
   PubMedGoogle Scholar
• Tripathy N. K., Patnaik K. K., Nabi Md. J. Acrylamide is genotoxic to me somatic and germ cells of Drosophila melanogaster. Mutat Res 1991; 259: 21–27
   PubMed Web of Science ®Google Scholar
• Tsuda H., Shimizu C. S., Taketomi M. K., Hasegawa M. M., Hamada A., Kawata K. M., Inui N. Acrylamide: Induction of DNA damage, chromosomal aberrations and cell transformation without gene mutations. Mutagenesis 1993; 8: 23–29
   PubMed Web of Science ®Google Scholar
• Voogd C. E., van der Stel J. J., Jacobs J. J. J. A. A. The mutagenic action of aliphatic epoxides. Mutat. Res. 1981; 89: 269–282
   PubMed Web of Science ®Google Scholar
• Walum E., Odland L., Romert L., Ekblad-Sekund G., Nilsson M., Calleman C. J., Bergmark E., Costa L. G. Biochemical approaches to neurotoxicology in vitro: Attempts to develop a test system for chemically induced axonopathy. Proc. Conf. In Vitro Toxicology: An Alternative to Animal Testing. Academic Press, London 1992
   Google Scholar
• Warr T. J., Parry J. H., Callander R. D., Ashby J. Methylvinyl sulphone: A new class of Michael-type genotoxin. Mutat. Res. 1990; 245: 191–199
   PubMedGoogle Scholar
• WHO. Acrylamide. Geneva 1985, Environmental Health Criteria No. 49
   Google Scholar
• Working P. K., Bentley K. S., Hum M., Mohr K. L. Comparison of the dominant lethal effects of acrylonitrile and acrylamide in male Fischer 344 rats. Mutagenesis 1987; 2: 215–220
   PubMed Web of Science ®Google Scholar